Recurrent hepatitis following halothane exposures

Lindenbaum, 1963, Hepatic necrosis associated with halothane anaesthesia, N Engl J Med, 268, 525, 10.1056/NEJM196303072681004 Strunin, 1972, Halothane in Britain today, Br J Anaesth, 44, 919, 10.1093/bja/44.9.919 Henderson, 1964, The incidence of post operative jaundice with special reference to halothane, Canad Anaesth Soc J, 11, 453, 10.1007/BF03005087 Trey, 1968, Fulminant hepatic failure. Presumable contribution by halothane, N Engl J Med, 279, 798, 10.1056/NEJM196810102791504 Klion, 1969, Hepatitis after exposure to halothane, Ann Intern Med, 71, 467, 10.7326/0003-4819-71-3-467 Sherlock, 1971, Halothane hepatitis, Gut, 12, 234, 10.1136/gut.12.4.324 Klatskin, 1969, Recurrent hepatitis attributable to halothane sensitization in an anaesthetist, N Engl J Med, 280, 515, 10.1056/NEJM196903062801001 Belfrage, 1966, Halothane hepatitis in anaesthetist, Lancet, 2, 1466, 10.1016/S0140-6736(66)90625-8 Thomas, 1974, Chronic aggressive hepatitis induced by halothane, Ann Intern Med, 81, 487, 10.7326/0003-4819-81-4-487 Carney, 1972, Postoperative hepatitis. I. Association of halothane with post operative hepatitis, Anaesth Analg, 51, 135 Christiansen, 1966, Liver function, histology, and cytochemistry in man following halothane and cyclopropane anaesthesia, Acta Med Scand, 180, 29, 10.1111/j.0954-6820.1966.tb02806.x Wright, 1975, Controlled prospective study of the effect on liver function of multiple exposures to halothane, Lancet, 12, 817, 10.1016/S0140-6736(75)93000-7 Dykes, 1965, Acute parenchymatous hepatic disease following general anaesthesia: clinical appraisal of hepatotoxicity following administration of halothane, JAMA, 193, 339, 10.1001/jama.1965.03090050015005 Fairlie, 1951, Comparison of effects of certain anesthetic agents in normal liver, N Engl J Med, 244, 615, 10.1056/NEJM195104262441701 Little, 1958, Effects of fluothane, cyclopropane, and ether anesthesias on liver function, Surg Gynecol Obstet, 107, 712 1966 Allen, 1964, A search for halothane liver complications, Anaesth Analg, 43, 159, 10.1213/00000539-196403000-00010 Gingrich, 1965, Postoperative liver damage. Is anesthesia involved?, Surgery, 57, 241 Paronetto, 1970, Lymphocyte stimulation induced by halothane in patients with hepatitis following exposure to halothane, N Engl J Med, 283, 277, 10.1056/NEJM197008062830602 Rodriguez, 1969, Antimitochondrial antibodies in jaundice following drug administration, JAMA, 208, 148, 10.1001/jama.1969.03160010144026 Mushin, 1971, Post-halthane jaundice in relation to previous administration of halothane, Br Med J, 2, 18, 10.1136/bmj.3.5765.18 Walton, 1976, Unexplained hepatitis following halothane, Br Med J, 1, 1171, 10.1136/bmj.1.6019.1171 Trowell, 1975, Controlled trial of repeated halothane anaesthetics in patients with carcinoma of the uterine cervix treated with radium, Lancet, 1, 821 Trey, 1969, The clinical syndrome of halothane hepatitis, Anesth Analg, 48, 1033, 10.1213/00000539-196911000-00031 Gottlieb, 1974, The effects of fluorinated anaesthetics on the liver and kidneys, Ann Rev Med, 25, 411, 10.1146/annurev.me.25.020174.002211 Berthelot, 1973, Mechanisms and prediction of drug-induced liver disease, Gut, 14, 332, 10.1136/gut.14.4.332 Klion, 1969, Clinical aids in diagnosis of halothane induced hepatitis, Gastroenterology, 56, 409 Peters, 1969, Hepatic necrosis associated with halothane anaesthesia, Am J Med, 47, 748, 10.1016/0002-9343(69)90168-5 Dordol, 1970, Fatal halothane hepatitis with transient granulomas, N Engl J Med, 283, 357, 10.1056/NEJM197008132830709 Uzunalimoglu, 1970, The liver in mild halothane hepatitis, Am J Pathol, 61, 457 Klatskin, 1972, Mitochondrial antibody in primary biliary cirrhosis and other diseases, Ann Intern Med, 77, 533, 10.7326/0003-4819-77-4-533 Soloway, 1972, Clinical, biochemical, and histological remission of severe chronic active liver disease. A controlled study of treatments and early prognosis, Gastroenterology, 32, 820, 10.1016/S0016-5085(19)33223-8 Murray-Lyon, 1973, Controlled trial of prednisone and azothioprine in active chronic hepatitis, Lancet, i, 735, 10.1016/S0140-6736(73)92125-9 1976, 8 Blum, 1969, A fortuitously con-trolled study of steroid therapy in acute viral hepatitis. I. Acute disease, Am J Med, 47, 82, 10.1016/0002-9343(69)90243-5 Miller, 1977, Follow-up of halothane hepatitis: Benign resolution of severe lesion, Gastroenterology, 73, A Simpson, 1973, Halothane hepatitis—fact or fancy?, 66, 56 Dykes, 1971, Unexplained post operative fever—its value as a sign of halothane sensitization, JAMA, 216, 641, 10.1001/jama.1971.03180300025005 Sharpstone, 1971, Halothane hepatitis—A preventable disease?, Br Med J, 1, 448, 10.1136/bmj.1.5746.448